Black Rock Inc. Mirum Pharmaceuticals, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 3,238,049 shares of MIRM stock, worth $168 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,238,049
Previous 2,452,273
32.04%
Holding current value
$168 Million
Previous $61.6 Million
79.72%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding MIRM
# of Institutions
229Shares Held
55.9MCall Options Held
27.4KPut Options Held
105K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.8MShares$352 Million19.27% of portfolio
-
Janus Henderson Group PLC London, X04.77MShares$247 Million0.12% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$145 Million5.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.54MShares$132 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.53MShares$131 Million2.42% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.91B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...